Colquhoun David R, Schwab Kellogg J, Cole Robert N, Halden Rolf U
JHU Center for Water and Health, Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, BSPH Bldg., Room E6618, Baltimore, MD 21205, USA.
Appl Environ Microbiol. 2006 Apr;72(4):2749-55. doi: 10.1128/AEM.72.4.2749-2755.2006.
Mass spectrometry (MS) represents a rapid technique for the identification of microbial monocultures, and its adaptation to the detection of pathogens in real-world samples is a public health and homeland security priority. Norovirus, a leading cause of gastroenteritis in the world, is difficult to monitor because it cannot be cultured outside the human body. The detection of norovirus capsid protein was explored using three common MS-based methods: scanning of intact proteins, peptide mass fingerprinting, and peptide sequencing. Detection of intact target protein was limited by poor selectivity and sensitivity. Detection of up to 16 target peptides by peptide mass fingerprinting allowed for the reproducible and confident (P < 0.05) detection of the 56-kDa norovirus capsid protein in the range of 0.1 x 10(-12) to 50 x 10(-12) mol in authentic standards of recombinant norovirus virus-like particles (VLPs). To explore assay performance in complex matrixes, a non-gel-based, rapid method (2 to 3 h) for virus extraction from human stool was evaluated (72% +/- 12% recovery), and additional analyses were performed on norovirus-free stool extracts fortified with VLPs. Whereas peptide mass fingerprinting was rendered impractical by sample interferences, peptide sequencing using nanospray tandem MS facilitated unambiguous identification of > or =250 fmol of capsid protein in stool extracts. This is the first report on MS-based detection of norovirus, accomplished by using structurally identical, noninfective VLPs at clinically relevant concentrations. It represents an important milestone in the development of assays for surveillance of this category B bioterrorism agent.
质谱分析法(MS)是一种用于鉴定微生物纯培养物的快速技术,使其适用于检测实际样本中的病原体是公共卫生和国土安全领域的优先事项。诺如病毒是全球肠胃炎的主要病因,由于无法在人体外培养,因此难以监测。本研究使用三种基于质谱的常用方法探索了诺如病毒衣壳蛋白的检测:完整蛋白质扫描、肽质量指纹图谱和肽测序。完整目标蛋白的检测受到选择性和灵敏度较差的限制。通过肽质量指纹图谱检测多达16种目标肽,可在重组诺如病毒病毒样颗粒(VLP)的真实标准品中,在0.1×10⁻¹²至50×10⁻¹²摩尔范围内可重复且可靠地(P<0.05)检测到56 kDa的诺如病毒衣壳蛋白。为了探索在复杂基质中的分析性能,评估了一种基于非凝胶的从人类粪便中快速提取病毒的方法(2至3小时)(回收率为72%±12%),并对添加了VLP的无诺如病毒粪便提取物进行了额外分析。虽然样品干扰使肽质量指纹图谱不切实际,但使用纳米喷雾串联质谱的肽测序有助于明确鉴定粪便提取物中≥250 fmol的衣壳蛋白。这是关于基于质谱检测诺如病毒的首次报告,通过使用临床相关浓度的结构相同、无感染性的VLP实现。它代表了监测这种B类生物恐怖主义病原体的检测方法开发中的一个重要里程碑。